Health Systems and Policy Research

contact@imedpub.com Submit a Manuscript

Hyperlipidemia Scholarly Peer-review Journal

Hyperlipidemia is an ailment portrayed by an expansion in at least one of the plasma lipids, including triglycerides, cholesterol, cholesterol esters, phospholipids or potentially plasma lipoproteins including low-thickness lipoprotein and low-thickness lipoprotein alongside decreased high-thickness lipoprotein levels. This rise of plasma lipids is among the main hazard factors related to cardiovascular sicknesses. Meanwhile, statins and fibrates remain the significant enemy of hyperlipidemic specialists for the treatment of raised plasma cholesterol and triglycerides individually, with the cost of extreme symptoms on the muscles and the liver. The current survey centers for the most part around the kinds of hyperlipidemias, lipid digestion, medicines, and new medication focuses on the treatment of raised lipid profiles. Numerous operators, for example, lanosterol synthase inhibitors, squalene epoxidase inhibitors, diacylglycerol acyltransferase inhibitors, ATP citrate lyase inhibitors have indicated a promising potential in the treatment of hyperlipidemia in clinical preliminaries.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Health Care & Nursing

Awards Nomination 17+ Million Readerbase
Google Scholar citation report
Citations : 337

Health Systems and Policy Research received 337 citations as per Google Scholar report

image
Abstracted/Indexed in
  • Google Scholar
  • China National Knowledge Infrastructure (CNKI)
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub

View More »

Open Access Journals